Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BNTC Benitec Biopharma

Not Yet Opened 12-20 16:00:00 EST

11.41

-0.76

-6.24%

盘后11.41

+0.000.00%

18:56 EST

High12.40	Low11.41	Vol562.05K
Open12.02	D1 Closing12.17	Amplitude8.13%
Mkt Cap264.90M	Tradable Cap121.88M	Total Shares23.22M
T/O6.48M	T/O Rate5.26%	Tradable Shares10.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BNTC","market":"US","secType":"STK","nameCN":"Benitec Biopharma","latestPrice":11.41,"timestamp":1734728400000,"preClose":12.17,"halted":0,"volume":562051,"hourTrading":{"tag":"盘后","latestPrice":11.41,"preClose":11.41,"latestTime":"18:56 EST","volume":161154,"amount":1838829.64,"timestamp":1734738960147},"delay":0,"floatShares":10681600,"shares":23216425,"eps":-3.373638,"marketStatus":"Not Yet Opened","change":-0.76,"latestTime":"12-20 16:00:00 EST","open":12.02,"high":12.4,"low":11.41,"amount":6478362.82079,"amplitude":0.081348,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.373638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":1,"adrRate":200,"listingDate":1439870400000,"exchange":"NASDAQ","adjPreClose":12.17,"preHourTrading":{"tag":"盘前","latestPrice":12.3,"preClose":12.17,"latestTime":"08:00 EST","volume":101,"amount":1242.49998,"timestamp":1734699603979},"postHourTrading":{"tag":"盘后","latestPrice":11.41,"preClose":11.41,"latestTime":"18:56 EST","volume":161154,"amount":1838829.64,"timestamp":1734738960147},"volumeRatio":8.267413252272545,"impliedVol":4.2015,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BNTC","defaultTab":"news","newsList":[{"id":"2492180158","title":"Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492180158","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492180158?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:18","pubTimestamp":1734535121,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, Benitec Biopharma's stock price might be vulnerable to their trading decisions. Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business. If you want to know who really controls Benitec Biopharma Inc. , then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are hedge funds with 38% ownership. Put another way, the group faces the maximum upside potential .Given the vast amount of money and research capacities at their disposal, hedge funds ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.Let's delve deeper into each type of owner of Benitec Biopharma, beginning with the chart below.Check out our latest analysis for Benitec Biopharma. What Does The Institutional Ownership Tell Us About ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hedge-funds-investors-own-significant-151841923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","IE00B3QW5Z07.USD","QLD","QID","NDAQ","BK4588","NVIW.SI","USAW.SI","TQQQ","IE00B64PRP62.GBP","BK4585",".IXIC","LU2210149790.SGD","NQmain","USJW.SI","BK4112","BK4139","TSYW.SI","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","LU2095319765.USD","SQQQ","BNTC","MNQmain"],"gpt_icon":1},{"id":"2492958270","title":"Benitec Biopharma initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2492958270","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492958270?lang=en_us&edition=fundamental","pubTime":"2024-12-17 19:25","pubTimestamp":1734434735,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju initiated coverage of Benitec Biopharma  with a Buy rating and $28 price target Benitec is a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference platform, the analyst tells investors in a research note. The firm says initial clinical findings “appear encouraging, with strong mechanistic rationale for therapeutic impact.”Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Benitec Biopharma initiated with an Outperform at Baird. BNTC Earnings Report this Week: Is It a Buy, Ahead of Earnings?","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/benitec-biopharma-initiated-buy-h-112535829.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/benitec-biopharma-initiated-buy-h-112535829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2491826660","title":"HC Wainwright Initiates Benitec Biopharma at Buy With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2491826660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491826660?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:21","pubTimestamp":1734351669,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $25.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTC"],"gpt_icon":0},{"id":"2491661581","title":"Benitec Biopharma Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2491661581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491661581?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:28","pubTimestamp":1734348523,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2491058126","title":"Benitec Biopharma Shakes Up Management Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2491058126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491058126?lang=en_us&edition=fundamental","pubTime":"2024-12-14 06:41","pubTimestamp":1734129660,"startTime":"0","endTime":"0","summary":"Benitec Biopharma appointed Sophie Mukadam as its chief operating officer and named executive director Megan Boston to its chief financial officer role.Mukadam will take the post effective Jan. 1 and will receive a base salary of $500,000 and a target annual bonus of 40% of her base salary, according to a Friday filing with the Securities and Exchange Commission.Mukadam has been serving as Benitec's associate director of program management, starting in May 2021. Before joining the company, she worked as a regulatory consultant. She holds a bachelor's degree from the University of California, Berkeley.Boston was appointed chief financial officer effective Jan. 1. She was also confirmed as the company's secretary. Boston will continue serving as the principal financial officer and principal accounting officer.Boston is set to receive $415,000 in annual salary, with a target annual discretionary bonus of 40% of that salary. She has been granted nonqualified stock options to purchase 720,0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","TISI","BK4139","BK4120"],"gpt_icon":0},{"id":"2491589117","title":"Benitec Biopharma Strengthens Leadership with Key Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2491589117","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491589117?lang=en_us&edition=fundamental","pubTime":"2024-12-14 05:49","pubTimestamp":1734126542,"startTime":"0","endTime":"0","summary":"Benitec Biopharma ( ($BNTC) ) has issued an announcement. Benitec Biopharma announced key executive appointments and compensation adjustments. Soph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-strengthens-leadership-with-key-appointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-strengthens-leadership-with-key-appointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2491830675","title":"Benitec Biopharma Inc - Megan Boston Confirmed as CFO and Secretary of Benitec Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2491830675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491830675?lang=en_us&edition=fundamental","pubTime":"2024-12-14 05:20","pubTimestamp":1734124857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2491324107","title":"Baird Initiates Benitec Biopharma at Outperform With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2491324107","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491324107?lang=en_us&edition=fundamental","pubTime":"2024-12-13 20:42","pubTimestamp":1734093721,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTC"],"gpt_icon":0},{"id":"2491312808","title":"Benitec Biopharma Inc : Baird Initiates Coverage With Outperform Rating; Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2491312808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491312808?lang=en_us&edition=fundamental","pubTime":"2024-12-13 15:13","pubTimestamp":1734074026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nFWN3NE024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2490770779","title":"Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490770779","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490770779?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:55","pubTimestamp":1733756105,"startTime":"0","endTime":"0","summary":"Benitec Biopharma Limited  closed the last trading session at $11.23, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24 indicates an 113.7% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $8.03. While the lowest estimate of $17 indicates a 51.4% increase from the current price level, the most optimistic analyst expects the stock to surge 211.7% to reach $35. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-see-113-145505203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2490774735","title":"Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2490774735","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490774735?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:50","pubTimestamp":1733752209,"startTime":"0","endTime":"0","summary":"Most of us have heard the dictum \"the trend is your friend.\" And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.Investors looking to make a profit from stocks that are currently on the move may find our \"Recent Price Strength\" screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.In addition to BNTC, there are several other stocks that currently pass through our \"Recent Price Strength\" screen. You may co","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/benitec-biopharma-bntc-great-choice-135009987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTC","ISBC","BK4211","BK4139","CHH","BK4142"],"gpt_icon":0},{"id":"2488928764","title":"Benitec Biopharma Price Target Maintained With a $17.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2488928764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488928764?lang=en_us&edition=fundamental","pubTime":"2024-12-04 00:50","pubTimestamp":1733244600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 03, 2024 11:50 ET (16:50 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2486071672","title":"Benitec Biopharma to Participate in Upcoming Investor Conferences in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2486071672","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486071672?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:00","pubTimestamp":1732622400,"startTime":"0","endTime":"0","summary":"HAYWARD, Calif., Nov.  26, 2024  (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987335/0/en/Benitec-Biopharma-to-Participate-in-Upcoming-Investor-Conferences-in-December.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRD","BK4139","BNTC"],"gpt_icon":0},{"id":"2484121998","title":"Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484121998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484121998?lang=en_us&edition=fundamental","pubTime":"2024-11-19 15:30","pubTimestamp":1732001429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Benitec Biopharma (BNTC – Research Report), Bluebird...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-bluebird-bio-blue-and-ac-immune-sa-aciu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-bluebird-bio-blue-and-ac-immune-sa-aciu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","BLUE","ACIU","BK4578","AC","BK4556","BK4139","BNTC","BK4137","HCSG"],"gpt_icon":0},{"id":"2484069758","title":"Analysts Are Bullish on These Healthcare Stocks: Steris (STE), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484069758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484069758?lang=en_us&edition=fundamental","pubTime":"2024-11-18 13:30","pubTimestamp":1731907819,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Steris (STE – Research Report), Benitec Biopharma (B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-steris-ste-benitec-biopharma-bntc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-steris-ste-benitec-biopharma-bntc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","STE","BK4139","HCSG","BK4585","BNTC","BK4082","LU1892829315.USD","BK4137"],"gpt_icon":0},{"id":"2483713013","title":"Benitec Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483713013","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483713013?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:06","pubTimestamp":1731679592,"startTime":"0","endTime":"0","summary":"* Benitec Biopharma Inc    reported a quarterly adjusted loss of 48 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-2.76.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Benitec Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2483356929","title":"Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483356929","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483356929?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:19","pubTimestamp":1731622790,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41993653/benitec-biopharma-q1-2025-gaap-eps-0-48-beats-0-55-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"gpt_icon":0},{"id":"2483989355","title":"Benitec Biopharma Awards Bonuses to Key Executives","url":"https://stock-news.laohu8.com/highlight/detail?id=2483989355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483989355?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:01","pubTimestamp":1731621715,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Benitec Biopharma ( ($BNTC) ). Benitec Biopharma Inc. has awarded discretionary bonuses to key executives for t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-awards-bonuses-to-key-executives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-awards-bonuses-to-key-executives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BNTC"],"gpt_icon":0},{"id":"2483358314","title":"Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358314?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA5KXVH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"gpt_icon":0},{"id":"2483358345","title":"Benitec Biopharma Q1 Operating Income USD -5.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358345?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:30","pubTimestamp":1731619800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLX243682:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.benitec.com","stockEarnings":[{"period":"1week","weight":-0.0306},{"period":"1month","weight":0.0704},{"period":"3month","weight":0.2269},{"period":"6month","weight":0.6584},{"period":"1year","weight":2.6454},{"period":"ytd","weight":2.5325}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.06227},{"month":2,"riseRate":0.555556,"avgChangeRate":0.110444},{"month":3,"riseRate":0.777778,"avgChangeRate":0.056589},{"month":4,"riseRate":0.333333,"avgChangeRate":0.02399},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.070564},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.119694},{"month":7,"riseRate":0.555556,"avgChangeRate":0.075553},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.028649},{"month":9,"riseRate":0.2,"avgChangeRate":-0.125403},{"month":10,"riseRate":0.6,"avgChangeRate":-0.045727},{"month":11,"riseRate":0.3,"avgChangeRate":-0.061846},{"month":12,"riseRate":0.5,"avgChangeRate":-0.05167}],"exchange":"NASDAQ","name":"Benitec Biopharma","nameEN":"Benitec Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Benitec Biopharma,BNTC,Benitec Biopharma股票,Benitec Biopharma股票老虎,Benitec Biopharma股票老虎国际,Benitec Biopharma行情,Benitec Biopharma股票行情,Benitec Biopharma股价,Benitec Biopharma股市,Benitec Biopharma股票价格,Benitec Biopharma股票交易,Benitec Biopharma股票购买,Benitec Biopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}